Hims & Hers Health (Hims & Hers Health) EBIT : $-8.3 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Hims & Hers Health EBIT?

Hims & Hers Health's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $9.9 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-8.3 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Hims & Hers Health's annualized ROC % for the quarter that ended in Mar. 2024 was 18.38%. Hims & Hers Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 77.39%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Hims & Hers Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -0.29%.

Hims & Hers Health EBIT Historical Data

The historical data trend for Hims & Hers Health's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hims & Hers Health EBIT Chart

Hims & Hers Health Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

-71.61

-15.14

-115.04

-68.70

-29.45

Hims & Hers Health Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial														-11.26	-9.24	-8.55	-0.40	9.90

Competitive Comparison of Hims & Hers Health's EBIT

For the Household & Personal Products subindustry, Hims & Hers Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hims & Hers Health's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Hims & Hers Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Hims & Hers Health's EV-to-EBIT falls into.

Hims & Hers Health EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.3 Mil.

Hims & Hers Health (NYSE:HIMS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Hims & Hers Health's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	39.612 * ( 1 - 10.28% )	/	( (185.147	+	201.651)	/ 2 )
=	35.5398864	/	193.399
=	18.38 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	441.186	-	79.454	-	( 220.981	-	max(0, 88.468	-	265.053	+	220.981	))
=	185.147

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	448.106	-	78.045	-	( 203.592	-	max(0, 93.324	-	261.734	+	203.592	))
=	201.651

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Hims & Hers Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	39.612	/	( ( (45.731 + max(-43.115, 0))	+	(56.634 + max(-33.638, 0)) )	/	2 )
=	39.612	/	( ( 45.731	+	56.634 )	/	2 )
=	39.612	/	51.1825
=	77.39 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(5.705	+	22.464	+	15.903)	-	(79.454	+	7.733	+	0)
=	-43.115

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(6.405	+	29.826	+	21.911)	-	(78.045	+	13.735	+	0)
=	-33.638

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Hims & Hers Health's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-8.287	/	2823.828
	=	-0.29 %

Hims & Hers Health EBIT Related Terms

Thank you for viewing the detailed overview of Hims & Hers Health's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Hims & Hers Health (Hims & Hers Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Hims & Hers Health Inc (NYSE:HIMS) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

82W:Germany

Address

2269 Chestnut Street, Suite 523, San Francisco, CA, USA, 94123

Website

https://www.forhims.com

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.

Executives

Andrew Dudum	director, 10 percent owner, officer: Chief Executive Officer	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Oluyemi Okupe	officer: Chief Financial Officer	2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Soleil Boughton	officer: See Remarks	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Lynne Chou O'keefe	director	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Irene Becklund	officer: Interim PFO/PAO	2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Melissa Baird	officer: Chief Operating Officer	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
David B Wells	director	C/O NETFLIX, INC., 100 WINCHESTER CIRCLE, LOS GATOS CA 95130
Alex Bard	director	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Ivp Executive Fund Xvi, Llc	10 percent owner	3000 SAND HILL ROAD, BUILDING 2, SUITE 2, MENLO PARK CA 94025
Jules A. Maltz	director	3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025
Christiane Pendarvis	director	2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Michael Chi	officer: Chief Marketing Officer	2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Somesh Dash	10 percent owner	3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025
Jack Abraham	10 percent owner	1 LETTERMAN DRIVE, SUITE C3500, SAN FRANCISCO CA 94129
Patrick Harrison Carroll	officer: Chief Medicall Officer	2269 CHESTNUT STREET, # 523, SAN FRANCISCO CA 94123